| ZTO | Name: | N-(3-{[(3R)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl]methyl}phenyl)-4-methoxybenzamide | Formula: | C23 H19 F N2 O3 | SMILES: | COc1ccc(cc1)C(=O)Nc1cccc(c1)CC1c2cc(F)ccc2NC1=O | InChi: | InChI=1S/C23H19FN2O3/c1-29-18-8-5-15(6-9-18)22(27)25-17-4-2-3-14(11-17)12-20-19-13-16(24)7-10-21(19)26-23(20)28/h2-11,13,20H,12H2,1H3,(H,25,27)(H,26,28)/t20-/m1/s1 | Definition date: | 2023-03-31 | Last modified: | 2024-09-27 | Release date: | 2024-03-27 | Identifier: | N-(3-{[(3R)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl]methyl}phenyl)-4-methoxybenzamide |
|
| V3C | Name: | Trans-4-athyl-L-proline | Formula: | C7 H13 N O2 | SMILES: | CC[CH]1CN[CH](C1)C(O)=O | InChi: | InChI=1S/C7H13NO2/c1-2-5-3-6(7(9)10)8-4-5/h5-6,8H,2-4H2,1H3,(H,9,10)/t5-,6+/m1/s1 | Synonyms: | (2S,4R)-4-ethylpyrrolidine-2-carboxylic acid | Definition date: | 2023-02-21 | Last modified: | 2024-09-27 | Release date: | 2023-11-29 | Identifier: | (2~{S},4~{R})-4-ethylpyrrolidine-2-carboxylic acid |
|
| T2Y | Name: | N-[(2H-1,3-benzodioxol-5-yl)methyl]acetamide | Formula: | C10 H11 N O3 | SMILES: | c2cc1c(OCO1)cc2CNC(C)=O | InChi: | InChI=1S/C10H11NO3/c1-7(12)11-5-8-2-3-9-10(4-8)14-6-13-9/h2-4H,5-6H2,1H3,(H,11,12) | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | N-[(2H-1,3-benzodioxol-5-yl)methyl]acetamide |
|
| UOT | Name: | 4-(2-chloranyl-6-methoxy-benzimidazol-1-yl)benzaldehyde | Formula: | C15 H11 Cl N2 O2 | SMILES: | COc1ccc2nc(Cl)n(c3ccc(C=O)cc3)c2c1 | InChi: | InChI=1S/C15H11ClN2O2/c1-20-12-6-7-13-14(8-12)18(15(16)17-13)11-4-2-10(9-19)3-5-11/h2-9H,1H3 | Definition date: | 2021-03-03 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-(2-chloranyl-6-methoxy-benzimidazol-1-yl)benzaldehyde |
|
| VJA | Name: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C26 H40 N4 O6 | SMILES: | c1ccc(cc1)COC(NC(C(C)C)C(=O)NC(C(NC(CO)CC2C(=O)NCC2)=O)CC(C)C)=O | InChi: | InChI=1S/C26H40N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,16-17,19-22,31H,10-15H2,1-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20+,21-,22-/m0/s1 | Definition date: | 2020-08-14 | Last modified: | 2024-09-27 | Release date: | 2021-10-13 | Identifier: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
| WEL | Name: | (1S,2S)-2-{[N-({2-[(1H-benzimidazol-2-yl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C25 H37 N5 O8 S2 | SMILES: | CC(C)CC(NC(=O)OCC(C)(C)Sc1nc2ccccc2[NH]1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C25H37N5O8S2/c1-14(2)11-18(21(32)27-19(22(33)40(35,36)37)12-15-9-10-26-20(15)31)30-24(34)38-13-25(3,4)39-23-28-16-7-5-6-8-17(16)29-23/h5-8,14-15,18-19,22,33H,9-13H2,1-4H3,(H,26,31)(H,27,32)(H,28,29)(H,30,34)(H,35,36,37)/t15-,18-,19-,22-/m0/s1 | Definition date: | 2022-09-05 | Last modified: | 2024-09-27 | Release date: | 2022-09-14 | Identifier: | (1S,2S)-2-{[N-({2-[(1H-benzimidazol-2-yl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
| V3D | Name: | (3S)-3-{[N-(4-methoxy-1H-indole-2-carbonyl)-L-leucyl]amino}-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl 2-cyanobenzoate | Formula: | C32 H35 N5 O7 | SMILES: | COc1cccc2c1cc(n2)C(NC(C(=O)NC(C(=O)COC(c3ccccc3C#N)=O)CC4CCNC4=O)CC(C)C)=O | InChi: | InChI=1S/C32H35N5O7/c1-18(2)13-25(37-31(41)26-15-22-23(35-26)9-6-10-28(22)43-3)30(40)36-24(14-19-11-12-34-29(19)39)27(38)17-44-32(42)21-8-5-4-7-20(21)16-33/h4-10,15,18-19,24-25,35H,11-14,17H2,1-3H3,(H,34,39)(H,36,40)(H,37,41)/t19-,24-,25-/m0/s1 | Definition date: | 2020-06-19 | Last modified: | 2024-09-27 | Release date: | 2020-07-08 | Identifier: | (3S)-3-{[N-(4-methoxy-1H-indole-2-carbonyl)-L-leucyl]amino}-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl 2-cyanobenzoate |
|
| XSA | Name: | (2R)-2-[(2-aminoethyl)amino]-4-boronobutanoic acid | Formula: | C6 H15 B N2 O4 | SMILES: | C(C(O)=O)(NCCN)CCB(O)O | InChi: | InChI=1S/C6H15BN2O4/c8-3-4-9-5(6(10)11)1-2-7(12)13/h5,9,12-13H,1-4,8H2,(H,10,11)/t5-/m1/s1 | Definition date: | 2021-01-08 | Last modified: | 2024-09-27 | Release date: | 2022-02-09 | Identifier: | (2R)-2-[(2-aminoethyl)amino]-4-boronobutanoic acid |
|
| VJB | Name: | bdaGDP | Formula: | C18 H29 N7 O13 P2 | SMILES: | CCC(=O)NCCCCNC(=O)O[CH]1[CH](O)[CH](O[CH]1CO[P](O)(=O)O[P](O)(O)=O)n2cnc3C(=O)N=C(N)Nc23 | InChi: | InChI=1S/C18H29N7O13P2/c1-2-10(26)20-5-3-4-6-21-18(29)37-13-9(7-35-40(33,34)38-39(30,31)32)36-16(12(13)27)25-8-22-11-14(25)23-17(19)24-15(11)28/h8-9,12-13,16,27H,2-7H2,1H3,(H,20,26)(H,21,29)(H,33,34)(H2,30,31,32)(H3,19,23,24,28)/t9-,12-,13-,16-/m1/s1 | Synonyms: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] ~{N}-[4-(propanoylamino)butyl]carbamate | Definition date: | 2021-05-18 | Last modified: | 2024-09-27 | Release date: | 2022-08-03 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] ~{N}-[4-(propanoylamino)butyl]carbamate |
|
| T3 | Name: | 3,5,3'TRIIODOTHYRONINE | Formula: | C15 H12 I3 N O4 | SMILES: | O=C(O)C(N)Cc2cc(I)c(Oc1cc(I)c(O)cc1)c(I)c2 | InChi: | InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1 | Synonyms: | T3 | Definition date: | 1999-07-12 | Last modified: | 2024-09-27 | Identifier: | O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine |
|
| UBB | Name: | 2',3'-DIDEOXY-URIDINE-5'-MONOPHOSPHATE | Formula: | C9 H13 N2 O7 P | SMILES: | O=C1NC(=O)N(C=C1)C2OC(CC2)COP(=O)(O)O | InChi: | InChI=1S/C9H13N2O7P/c12-7-3-4-11(9(13)10-7)8-2-1-6(18-8)5-17-19(14,15)16/h3-4,6,8H,1-2,5H2,(H,10,12,13)(H2,14,15,16)/t6-,8+/m0/s1 | Definition date: | 2003-02-13 | Last modified: | 2024-09-27 | Identifier: | [(2S,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl dihydrogen phosphate |
|
| XC4 | Name: | 1-[(1H-indole-5-carbonyl)oxy]-1H-benzotriazole | Formula: | C15 H10 N4 O2 | SMILES: | c2cc1nccc1cc2C(=O)On3c4c(nn3)cccc4 | InChi: | InChI=1S/C15H10N4O2/c20-15(11-5-6-12-10(9-11)7-8-16-12)21-19-14-4-2-1-3-13(14)17-18-19/h1-9,16H | Definition date: | 2020-12-09 | Last modified: | 2024-09-27 | Release date: | 2020-12-16 | Identifier: | 1-[(1H-indole-5-carbonyl)oxy]-1H-benzotriazole |
|
| THO | Name: | REDUCED THREONINE | Formula: | C4 H11 N O2 | SMILES: | OCC(N)C(O)C | InChi: | InChI=1S/C4H11NO2/c1-3(7)4(5)2-6/h3-4,6-7H,2,5H2,1H3/t3-,4-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R,3R)-2-aminobutane-1,3-diol |
|
| TWE | Name: | 1-(4-methanoylphenyl)carbonylpiperidine-4-carbonitrile | Formula: | C14 H14 N2 O2 | SMILES: | O=Cc1ccc(cc1)C(=O)N2CCC(CC2)C#N | InChi: | InChI=1S/C14H14N2O2/c15-9-11-5-7-16(8-6-11)14(18)13-3-1-12(10-17)2-4-13/h1-4,10-11H,5-8H2 | Definition date: | 2021-01-14 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 1-(4-methanoylphenyl)carbonylpiperidine-4-carbonitrile |
|
| 42X | Name: | N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-[2-(propanoylamino)ethyl]-beta-alaninamide | Formula: | C14 H28 N3 O8 P | SMILES: | O=P(OCC(C(O)C(=O)NCCC(=O)NCCNC(=O)CC)(C)C)(O)O | InChi: | InChI=1S/C14H28N3O8P/c1-4-10(18)15-7-8-16-11(19)5-6-17-13(21)12(20)14(2,3)9-25-26(22,23)24/h12,20H,4-9H2,1-3H3,(H,15,18)(H,16,19)(H,17,21)(H2,22,23,24)/t12-/m0/s1 | Definition date: | 2015-01-23 | Last modified: | 2024-09-27 | Release date: | 2016-01-27 | Identifier: | N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-[2-(propanoylamino)ethyl]-beta-alaninamide |
|
| WEQ | Name: | (1~{R},2~{S})-2-[[(2~{S})-2-[[2-(1~{H}-benzimidazol-2-ylsulfanyl)-2-methyl-propoxy]carbonylamino]-4-methyl-pentanoyl]amino]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propane-1-sulfonic acid;molecular oxygen | Formula: | C25 H37 N5 O8 S2 | SMILES: | CC(C)CC(NC(=O)OCC(C)(C)Sc1nc2ccccc2[NH]1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C25H37N5O8S2/c1-14(2)11-18(21(32)27-19(22(33)40(35,36)37)12-15-9-10-26-20(15)31)30-24(34)38-13-25(3,4)39-23-28-16-7-5-6-8-17(16)29-23/h5-8,14-15,18-19,22,33H,9-13H2,1-4H3,(H,26,31)(H,27,32)(H,28,29)(H,30,34)(H,35,36,37)/t15-,18-,19-,22+/m0/s1 | Definition date: | 2022-09-05 | Last modified: | 2024-09-27 | Release date: | 2022-09-14 | Identifier: | (1R,2S)-2-{[N-({2-[(1H-benzimidazol-2-yl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
| UOX | Name: | 3-(oxido-lambda~4~-selanyl)-L-alanine | Formula: | C3 H6 N O3 Se | SMILES: | O=C(O)C(N)C[SeH]=O | InChi: | InChI=1S/C3H6NO3Se/c4-2(1-8-7)3(5)6/h2H,1,4H2,(H,5,6)/q-1/t2-/m0/s1 | Definition date: | 2013-06-13 | Last modified: | 2024-09-27 | Identifier: | 3-(oxido-lambda~4~-selanyl)-L-alanine |
|
| K46 | Name: | ~{N}-[(3~{S})-5-azanyl-1-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2~{H}-quinolin-3-yl]propanamide | Formula: | C19 H20 F3 N3 O | SMILES: | CCC(=O)N[CH]1CN(c2ccc(cc2)C(F)(F)F)c3cccc(N)c3C1 | InChi: | InChI=1S/C19H20F3N3O/c1-2-18(26)24-13-10-15-16(23)4-3-5-17(15)25(11-13)14-8-6-12(7-9-14)19(20,21)22/h3-9,13H,2,10-11,23H2,1H3,(H,24,26)/t13-/m0/s1 | Definition date: | 2023-08-11 | Last modified: | 2024-09-27 | Release date: | 2023-10-04 | Identifier: | ~{N}-[(3~{S})-5-azanyl-1-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2~{H}-quinolin-3-yl]propanamide |
|
| 42Y | Name: | O-propanoyl-L-serine | Formula: | C6 H11 N O4 | SMILES: | O=C(OCC(C(=O)O)N)CC | InChi: | InChI=1S/C6H11NO4/c1-2-5(8)11-3-4(7)6(9)10/h4H,2-3,7H2,1H3,(H,9,10)/t4-/m0/s1 | Definition date: | 2015-01-23 | Last modified: | 2024-09-27 | Release date: | 2016-01-27 | Identifier: | O-propanoyl-L-serine |
|
| V3K | Name: | 4-methanoyl-~{N}-[(1-methylpyrazol-4-yl)methyl]benzamide | Formula: | C13 H13 N3 O2 | SMILES: | Cn1cc(CNC(=O)c2ccc(C=O)cc2)cn1 | InChi: | InChI=1S/C13H13N3O2/c1-16-8-11(7-15-16)6-14-13(18)12-4-2-10(9-17)3-5-12/h2-5,7-9H,6H2,1H3,(H,14,18) | Definition date: | 2021-04-09 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-methanoyl-~{N}-[(1-methylpyrazol-4-yl)methyl]benzamide |
|
| WW2 | Name: | cyclohexyl (S)-methylphosphonofluoridoate | Formula: | C7 H14 F O2 P | SMILES: | O=P(F)(OC1CCCCC1)C | InChi: | InChI=1S/C7H14FO2P/c1-11(8,9)10-7-5-3-2-4-6-7/h7H,2-6H2,1H3/t11-/m0/s1 | Synonyms: | Cyclosarin | Definition date: | 2009-10-22 | Last modified: | 2024-09-27 | Identifier: | cyclohexyl (S)-methylphosphonofluoridate |
|
| WET | Name: | L-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | Formula: | C10 H11 N O3 | SMILES: | OC(=O)[CH]1Cc2ccc(O)cc2CN1 | InChi: | InChI=1S/C10H11NO3/c12-8-2-1-6-4-9(10(13)14)11-5-7(6)3-8/h1-3,9,11-12H,4-5H2,(H,13,14)/t9-/m0/s1 | Synonyms: | (3~{S})-7-oxidanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | Definition date: | 2023-10-03 | Last modified: | 2024-09-27 | Release date: | 2024-03-27 | Identifier: | (3~{S})-7-oxidanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
|
| V3M | Name: | 2-deoxy-2-fluoro-alpha-D-arabinofuranose | Formula: | C5 H9 F O4 | SMILES: | OC1OC(CO)C(C1F)O | InChi: | InChI=1S/C5H9FO4/c6-3-4(8)2(1-7)10-5(3)9/h2-5,7-9H,1H2/t2-,3+,4-,5+/m1/s1 | Definition date: | 2020-06-20 | Last modified: | 2024-09-27 | Release date: | 2020-07-01 | Identifier: | 2-deoxy-2-fluoro-alpha-D-arabinofuranose |
|
| S9U | Name: | [(1~{R},2~{R})-2-(cyclohexylmethyl)cyclopropyl]methyl ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate | Formula: | C25 H44 N3 O8 S | SMILES: | CC(C)C[CH](NC(=O)OC[CH]1C[CH]1CC2CCCCC2)C(=O)N[CH](C[CH]3CCNC3=O)[CH](O)[S+](O)(O)=O | InChi: | InChI=1S/C25H43N3O8S/c1-15(2)10-20(28-25(32)36-14-19-12-18(19)11-16-6-4-3-5-7-16)23(30)27-21(24(31)37(33,34)35)13-17-8-9-26-22(17)29/h15-21,24,31H,3-14H2,1-2H3,(H4-,26,27,28,29,30,32,33,34,35)/p+1/t17-,18+,19-,20-,21-,24-/m0/s1 | Definition date: | 2022-06-29 | Last modified: | 2024-09-27 | Release date: | 2022-07-06 | Identifier: | [(1~{R},2~{R})-2-(cyclohexylmethyl)cyclopropyl]methyl ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate |
|
| XSN | Name: | L-alpha-asparagine | Formula: | C4 H8 N2 O3 | SMILES: | O=C(N)C(N)CC(=O)O | InChi: | InChI=1S/C4H8N2O3/c5-2(4(6)9)1-3(7)8/h2H,1,5H2,(H2,6,9)(H,7,8)/t2-/m0/s1 | Definition date: | 2011-05-13 | Last modified: | 2024-09-27 | Identifier: | L-alpha-asparagine |
|